Literature DB >> 27409293

Immunization of HIV-infected adult patients - French recommendations.

Anne Frésard1,2, Amandine Gagneux-Brunon1,2, Frédéric Lucht1,2,3, Elisabeth Botelho-Nevers1,2,3, Odile Launay3,4,5,6.   

Abstract

Human immunodeficiency virus (HIV)-infected patients remain at increased risk of infection including vaccine-preventable diseases. Vaccines are therefore critical components in the protection of HIV-infected patients from an increasing number of preventable diseases. However, missed opportunities for vaccination among HIV-infected patients persist and vaccine coverage in this population could be improved. This article presents the French recommendations regarding immunization of HIV-infected adults in the light of the evidence-based literature on the benefits and the potential risks of vaccines among this vulnerable population.

Entities:  

Keywords:  HIV infection; immunization; immunocompromised patients; influenza; live vaccines; pneumococcal infections; recommendations; vaccine; vaccine-preventable diseases

Mesh:

Year:  2016        PMID: 27409293      PMCID: PMC5137523          DOI: 10.1080/21645515.2016.1207013

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  94 in total

1.  The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.

Authors:  S C Redd; G W Rutherford; M A Sande; A R Lifson; W K Hadley; R R Facklam; J S Spika
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011.

Authors:  Jean-Paul Guthmann; Laure Fonteneau; Isabelle Bonmarin; Daniel Lévy-Bruhl
Journal:  Vaccine       Date:  2011-12-15       Impact factor: 3.641

3.  Immunogenicity of a meningococcal serogroup C conjugate vaccine in HIV-infected children, adolescents, and young adults.

Authors:  Daniela Vinhas Bertolini; Luciana Scarlazzari Costa; Inneke Marie van der Heijden; Helena Keiko Sato; Heloísa Helena de Sousa Marques
Journal:  Vaccine       Date:  2012-07-06       Impact factor: 3.641

Review 4.  Yellow fever vaccine for patients with HIV infection.

Authors:  Hilary Barte; Tara H Horvath; George W Rutherford
Journal:  Cochrane Database Syst Rev       Date:  2014-01-23

5.  Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults.

Authors:  Vania Giacomet; Francesca Penagini; Daria Trabattoni; Alessandra Viganò; Veronica Rainone; Giada Bernazzani; Claudia Maria Bonardi; Mario Clerici; Giorgio Bedogni; Gian Vincenzo Zuccotti
Journal:  Vaccine       Date:  2014-08-20       Impact factor: 3.641

6.  HIV care: A missed opportunity for immunization.

Authors:  Amandine Gagneux-Brunon; Frédéric Lucht; Elisabeth Botelho-Nevers
Journal:  Vaccine       Date:  2016-03-19       Impact factor: 3.641

7.  Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Kenneth Wilkins; Andrew W Lee; Anthony Grosso; Michael L Landrum; Amy Weintrob; Anuradha Ganesan; Jason Maguire; Stephanie Klopfer; Carolyn Brandt; William P Bradley; Mark R Wallace; Brian K Agan
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

8.  Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.

Authors:  Philippe Lesprit; Gaëlle Pédrono; Jean-Michel Molina; Cécile Goujard; Pierre-Marie Girard; Nathalie Sarrazin; Christine Katlama; Patrick Yéni; Pascale Morineau; Jean-François Delfraissy; Geneviève Chêne; Yves Lévy
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

9.  Community-Based Outbreak of Neisseria meningitidis Serogroup C Infection in Men who Have Sex with Men, New York City, New York, USA, 2010-2013.

Authors:  Molly M Kratz; Don Weiss; Alison Ridpath; Jane R Zucker; Anita Geevarughese; Jennifer Rakeman; Jay K Varma
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

10.  Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.

Authors:  Alasdair Bamford; Peter Kelleher; Hermione Lyall; Mitch Haston; Marta Zancolli; David Goldblatt; Beate Kampmann
Journal:  AIDS       Date:  2014-09-10       Impact factor: 4.177

View more
  6 in total

Review 1.  Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.

Authors:  Nancy F Crum-Cianflone; Eva Sullivan
Journal:  Infect Dis Ther       Date:  2017-08-05

Review 2.  Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.

Authors:  Nancy F Crum-Cianflone; Eva Sullivan
Journal:  Infect Dis Ther       Date:  2017-08-04

3.  Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project.

Authors:  Elena Santagostino; Agostino Riva; Simone Cesaro; Susanna Esposito; Davide Matino; Renata Ilde Mazzucchelli; Angelo Claudio Molinari; Rosamaria Mura; Lucia Dora Notarangelo; Annarita Tagliaferri; Giovanni Di Minno; Mario Clerici
Journal:  Haemophilia       Date:  2019-04-16       Impact factor: 4.287

Review 4.  A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency.

Authors:  Elda Righi; Tolinda Gallo; Anna Maria Azzini; Fulvia Mazzaferri; Maddalena Cordioli; Mara Merighi; Evelina Tacconelli
Journal:  Infect Dis Ther       Date:  2021-03-09

5.  Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study.

Authors:  Yanmeng Feng; Yifan Zhang; Zhangyufan He; Haojie Huang; Xiangxiang Tian; Gang Wang; Daihong Chen; Yanqin Ren; Liqiu Jia; Wanhai Wang; Jing Wu; Lingyun Shao; Wenhong Zhang; Heng Tang; Yanmin Wan
Journal:  EClinicalMedicine       Date:  2021-12-04

6.  Low immunity against vaccine preventable diseases in Turkish HIV cohort

Authors:  Aslihan Candevir; Ferit Kuşcu; Figen Yildirim; Süheyla Kömür; Gönül Çiçek Şentürk; Ayşe Seza Inal; Fatma Eser; Salih Çetiner; Behice Kurtaran; Yeşim Taşova
Journal:  Turk J Med Sci       Date:  2021-10-21       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.